Stock Taper
SCREENER COMPARE ANY 2 STOCKS
BOLD
BOUNDLESS BIO, INC.
NASDAQ
$2.87
▼ DOWN 0.69% (0.00)

KEY STATISTICS

Market Cap$64.50 M
52w High$3.16
52w Low$0.96
Dividend Yield—
Frequency—
P/E-1.00
Volume20.00K
Shares Out.22.47M

COMPANY

LEADERSHIP

Zachary Hornby
CHIEF EXECUTIVE
Zachary Hornby

COMPENSATION 2026

Salary$638,000
Stock Awards$0
Incentive Plan Pay$333,355
All Other Comp.$3,500
Total$1,603,205

ABOUT

SECTOR
Healthcare
WENT PUBLIC
March 28, 2024
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
28

UPCOMING EARNINGS

DateNov 5, 2026
DayThursday
Rev. Est.—
NOV
5
THU

PRICE

$2.87 ▼ DOWN 0.69% (−$0.00)
$2.85$2.87$2.889:33 AM10:37 AM11:42 AM12:46 PM1:50 PM2:55 PM3:59 PM2.87

About Boundless Bio, Inc.

https://boundlessbio.com ↗

Boundless Bio, Inc., a San Diego-based clinical-stage oncology company, develops cancer therapeutics targeting extrachromosomal DNA, with lead candidates BBI-355 and BBI-825 in Phase 1/2 trials for oncogene-amplified and resistant cancers.

INDUSTRY

Biotechnology

A PRODUCT BOUNDLESS BIO, INC. IS KNOWN FOR

BBI-940
BBI-940

BBI-940 is a clinical-stage oral Kinesin degrader developed by Boundless Bio as a potential cancer therapy, with an IND accepted by the FDA and a first-in-human trial planned for early 2026 in metastatic breast cancer.

COMPETITORS

COMPETITOR
FHTX COMPARE
GLUE COMPARE
KURA COMPARE
RLAY COMPARE
RVMD COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
12
LISTED HERE
2
RANKED BY POSITION SIZE
VTS.AX
0.00% · 445.2K
IWC
0.01% · 58.5K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
56.03%
HOLDERS
67
TOP 12 OF 67 · RANKED BY POSITION SIZE
Fmr LLC
3.1M sh · $3.81M
Bb Biotech AG
1.4M sh · $53.44M
Citadel Advisors LLC
1.4M sh · $1.62M
Nextech Invest, Ltd.
1.2M sh · $1.51M
Nextech Invest Ltd.
1.2M sh · $3.56M
Boxer Capital, LLC
711.3K sh · $2.47M
Stonepine Capital Management, LLC
710.1K sh · $852.09K
Sectoral Asset Management Inc
678.6K sh · $746.43K
Vanguard Group Inc
662.8K sh · $795.31K
Wellington Management Group Llp
556.2K sh · $611.86K
Blackrock Inc.
517.1K sh · $2M
Blackrock Fund Advisors
478.4K sh · $8.74M

RATINGS SNAPSHOT

Overall rating: C-

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book4
Overall Score1

INSIDER TRADES

★
10 PERCENT OWNER
TANG KEVIN
Sale · 18.3K shares
2026-08-26
★
10 PERCENT OWNER
TANG KEVIN
Purchase · 1.6K shares
2026-07-20
★
10 PERCENT OWNER
TANG KEVIN
Purchase · 265 shares
2026-07-17
★
10 PERCENT OWNER
TANG KEVIN
Purchase · 3.0K shares
2026-07-21

SECTORS PEERS

PEERPRICE
QTTB$12.07COMPARE
ANTX$5.91COMPARE
RLYB$16.94COMPARE
TAOX$3.82COMPARE
NXTC$7.88COMPARE
PLUR$1.44COMPARE
INTS$4.10COMPARE